Further influence from the tumor microenvironment, metastatic site, or therapeutic pressure may have also played key roles in the transition from AMPC to NEPC in our case, and this places further emphasis on RB1 function on prostate cancer progression41,42. This evidence concerns the gene RB1 and prostate carcinoma.